Matthew Hogan, Daniel Caserza, Quest Diagnostics, Affymetrix, Promega, Takara Bio, Beckman Coulter, Molecular Research Center | GenomeWeb


Matthew Hogan, Ciphergen's chief financial officer, has resigned, according to documents filed by the company with the US Securities and Exchange Commission last week.

Hogan will "provide consulting services" to the company and receive his current salary for up to six months, according to the filing.

Daniel Caserza was named interim CFO. Caserza joined Ciphergen in 1999. He became a vice president in April 2005.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.